Bisaro Paul bought MYGN
May 14, 2026 · Form 4 insider transaction
Bisaro Paul bought 7,500 shares of Myriad Genetics, Inc. at $3.69 per share, a transaction worth $27.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$3.69
Total value
$27.6K
InsiderBisaro Paul
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 14, 2026
Filing dateMay 14, 2026
Shares owned after97,441
OwnershipDirect
10b5-1 planNo
AmendedNo